Kat2B — Lysine Acetyltransferase 2B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| KAT2B | |
|---|---|
| Gene Symbol | KAT2B |
| Full Name | Lysine Acetyltransferase 2B (PCAF) |
| Chromosome | 3p24.3 |
| NCBI Gene ID | 10524 |
| OMIM | 602303 |
| Ensembl ID | ENSG00000114166 |
| UniProt ID | Q92830 |
| Associated Diseases | Neurodevelopmental Disorders, Alzheimer's Disease, Cancer |
KAT2B (also known as PCAF - p300/CBP-associated factor) encodes a histone acetyltransferase that plays a crucial role in transcriptional regulation through chromatin remodeling. It acetylates histone H3 and H4, leading to an open chromatin structure and enhanced gene expression.
In the nervous system, KAT2B is involved in:
Expressed throughout the brain with high expression in the hippocampus, cortex, and cerebellum. KAT2B is a transcriptional coactivator that localizes to the nucleus.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Neurodevelopmental Disorders | Rare variants | Complex | Altered histone acetylation |
| Alzheimer's Disease | Risk variants | Complex | Impaired epigenetic regulation |
| Cancer | Overexpression | Acquired | Altered transcriptional control |
The study of Kat2B — Lysine Acetyltransferase 2B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The KAT2B Gene is involved in various cellular processes in the nervous system. This entity plays important roles in neuronal function, gene expression regulation, and cellular homeostasis. Dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
The KAT2B Gene participates in multiple molecular pathways critical for neuronal health. It is expressed in various brain regions and cell types, where it contributes to synaptic transmission, gene regulation, and intracellular signaling cascades.
Alterations in KAT2B Gene expression or function have been associated with several neurodegenerative conditions. Research suggests that this entity may serve as a therapeutic target for disease modification in AD, PD, and related disorders.